Lætitia Fartoux
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease Diagnosis and Treatment, Metabolism, Diabetes, and Cancer, Cancer, Hypoxia, and Metabolism, Cholangiocarcinoma and Gallbladder Cancer Studies
Most-Cited Works
- → Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial(2018)2,498 cited
- → The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids(2007)718 cited
- → Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study(2013)593 cited
- → Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study(2019)511 cited
- → Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial(2014)412 cited
- → Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C(2005)374 cited
- → Early Change in Bilirubin Levels Is An Important Prognostic Factor in Severe Alcoholic Hepatitis Treated With Prednisolone(2003)202 cited
- → Impact of steatosis on progression of fibrosis in patients with mild hepatitis C(2004)191 cited
- → Detection of Hepatocellular Carcinoma with PET/CT: A Prospective Comparison of18F-Fluorocholine and18F-FDG in Patients with Cirrhosis or Chronic Liver Disease(2010)190 cited
- → Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells(2012)174 cited